CCM
CVS icon

Coldstream Capital Management’s CVS Health CVS Stock Holding History

Coldstream Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43M Buy
23,465
+1,090
+5% +$97.3K 0.03% 264
2026
Q1 		$1.61M Buy
22,375
+2,027
+10% +$156K 0.02% 348
2025
Q4 		$1.61M Buy
20,348
+1,333
+7% +$105K 0.02% 336
2025
Q3 		$1.43M Buy
19,015
+1,381
+8% +$94.6K 0.02% 378
2025
Q2 		$1.22M Sell
17,634
-648
-4% -$42.5K 0.02% 379
2025
Q1 		$1.24M Buy
18,282
+5,930
+48% +$355K 0.03% 340
2024
Q4 		$554K Sell
12,352
-5,048
-29% -$283K 0.01% 563
2024
Q3 		$1.08M Buy
17,400
+3,788
+28% +$221K 0.02% 356
2024
Q2 		$804K Sell
13,612
-6,682
-33% -$418K 0.02% 378
2024
Q1 		$1.62M Buy
20,294
+727
+4% +$55.5K 0.04% 244
2023
Q4 		$1.54M Buy
19,567
+1,598
+9% +$114K 0.04% 223
2023
Q3 		$1.25M Buy
17,969
+1,715
+11% +$122K 0.04% 238
2023
Q2 		$1.12M Buy
16,254
+254
+2% +$18.1K 0.04% 250
2023
Q1 		$1.19M Sell
16,000
-3,733
-19% -$313K 0.04% 249
2022
Q4 		$1.84M Buy
+19,733
New +$1.9M 0.07% 181
2022
Q2 		$1.39M Buy
14,963
+619
+4% +$60.4K 0.05% 192
2022
Q1 		$1.45M Sell
14,344
-745
-5% -$78.3K 0.05% 198
2021
Q4 		$1.56M Buy
15,089
+10,858
+257% +$1M 0.05% 200
2021
Q3 		$247K Sell
4,231
-3,947
-48% -$331K 0.01% 341
2021
Q2 		$682K Buy
8,178
+2,760
+51% +$226K 0.03% 239
2021
Q1 		$408K Buy
5,418
+723
+15% +$52.7K 0.02% 252
2020
Q4 		$321K Buy
4,695
+1,101
+31% +$71.6K 0.02% 272
2020
Q3 		$210K Sell
3,594
-999
-22% -$62.2K 0.02% 290
2020
Q2 		$299K Buy
4,593
+669
+17% +$42.1K 0.03% 229
2020
Q1 		$233K Sell
3,924
-437
-10% -$29.2K 0.03% 233
2019
Q4 		$324K Buy
4,361
+1,084
+33% +$76.1K 0.03% 248
2019
Q3 		$207K Buy
+3,277
New +$194K 0.02% 313

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Coldstream Capital Management's CVS Position: Q2 2026 in Review

Coldstream Capital Management increased its CVS Health (CVS) stake by 4.9% in Q2 2026, buying an estimated $97.3K and bringing the position to 23,465 shares worth $2.43M. The position accounts for 0.03% of the portfolio, ranked #264.

Coldstream Capital Management first reported a position in CVS in Q3 2019 and has held it in 27 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Coldstream Capital Management held 23,465 shares of CVS Health worth $2.43M as of Q2 2026.
  • Coldstream Capital Management bought 1,090 CVS Health shares in Q2 2026, an estimated $97.3K.
  • CVS Health made up 0.03% of Coldstream Capital Management's portfolio in Q2 2026, its #264 holding.
  • Coldstream Capital Management first reported a position in CVS Health in Q3 2019 and has held it in 27 quarters since.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.